Disclosure of Shareholdings in Accordance with Stock Market Rules
August 05, 2008 11:31 ET
|
Addex Therapeutics
Geneva, Switzerland, 5 August 2008 - Addex Pharmaceuticals (SWX:ADXN) announced today that on July 31, 2008, The Swiss Helvetia Fund, Inc. 1270 Avenue of the Americas, Suite 400, New York, NY...
Addex Pharmaceuticals Reports First Half 2008 Financial Results, Maiden Profit
July 28, 2008 01:00 ET
|
Addex Therapeutics
Français (PDF)
Deutsch (PDF)
English (PDF)
Geneva, Switzerland, 28 July 2008 - Addex Pharmaceuticals (SWX:ADXN) released today financial results for the first...
Addex Appoints Laurent Galibert Head of Inflammation Business Unit
July 28, 2008 00:50 ET
|
Addex Therapeutics
Français (PDF)
Deutsch (PDF)
English (PDF)
Geneva, Switzerland, 28 July 2008 - Addex Pharmaceuticals is pleased to announce the appointment of Laurent Galibert to its...
Addex First Half 2008 Financial Results Monday, July 28
July 18, 2008 09:14 ET
|
Addex Therapeutics
Geneva, Switzerland, 18 July 2008 - Addex Pharmaceuticals Ltd. (SWX:ADXN) will discuss its financial results for the first half of 2008 and give a pipeline update during a teleconference and...
Addex Pharmaceuticals Starts Phase I ADX10059 Interaction Study
June 04, 2008 01:00 ET
|
Addex Therapeutics
New formulation of ADX10059 selected
German PDF French PDF English PDF Geneva, Switzerland, 4 June 2008 - Addex Pharmaceuticals (SWX:ADXN) announced that it has started Study...
Disclosure of Shareholdings in Accordance with Stock Market Rules
May 27, 2008 01:00 ET
|
Addex Therapeutics
Geneva, Switzerland, 27 May 2008 - Addex Pharmaceuticals Ltd. (SWX:ADXN) disclosed the following shareholdings.
Addex Pharmaceuticals Ltd. was informed by:
Sofinnova Capital IV FCPR(1)...
Addex Starts ADX10059 Phase I Formulation Selection Study
April 24, 2008 01:00 ET
|
Addex Therapeutics
Geneva, Switzerland, 24 April 2008 - Addex Pharmaceuticals (SWX:ADXN) announced that it has begun Phase I testing of two formulations of ADX10059 and that it will elaborate on ADX10059 development and...
Addex Shareholders Elect Ray Hill to Board of Directors at the 2008 Annual General Meeting
April 18, 2008 01:00 ET
|
Addex Therapeutics
Shareholders Approve All Board Proposals at 2008 AGMGeneva, Switzerland, 18 April 2008 - Addex Pharmaceuticals Ltd. (SWX:ADXN) announced that its shareholders approved all the proposals of...
Addex Appoints Laurent Massuyeau as Head of Business Development
April 18, 2008 01:00 ET
|
Addex Therapeutics
Geneva, Switzerland, 18 April 2008 - Addex Pharmaceuticals is pleased to announce the appointment of Laurent Massuyeau as head of business development.
Mr. Massuyeau joins Addex from...
Addex Pharmaceuticals R&D Day on April 24
March 28, 2008 02:00 ET
|
Addex Therapeutics
Addex 2007 Annual Report Now Available
Geneva, Switzerland, 28 March 2008 - Addex Pharmaceuticals (SWX:ADXN) invites investors, analysts and media to attend its first R&D day on Thursday,...